Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 03, 2023 Filed Jan 5, 2023 21:30 UTC |
Kinney Catherine RDirector
|
GrantCommon Stock | 520 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-23-000032 · wf-form4_167295418787528.xml · nonDerivative · entry 1 Kinney Catherine R · CIK 0001205054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,514 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:29 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 953 | $72.15 | $68,758.95 |
DisclosureSEC source: 0001099219-23-000031 · wf-form4_167295416137518.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,124 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:29 UTC |
KELLY EDWARD J IIIDirector
|
GrantCommon Stock | 520 | $72.15 | $37,518.00 |
DisclosureSEC source: 0001099219-23-000030 · wf-form4_167295413463105.xml · nonDerivative · entry 1 KELLY EDWARD J III · CIK 0001160225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,808 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:28 UTC |
Kennard William EDirector
|
GrantCommon Stock | 520 | $72.15 | $37,518.00 |
DisclosureSEC source: 0001099219-23-000029 · wf-form4_167295410318710.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,303 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:27 UTC |
MORRISON DENISE MDirector
|
GrantCommon Stock | 520 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-23-000026 · wf-form4_167295403363378.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,475 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:28 UTC |
GRISE CHERYL WDirector
|
GrantCommon Stock | 520 | $72.15 | $37,518.00 |
DisclosureSEC source: 0001099219-23-000028 · wf-form4_167295407591539.xml · nonDerivative · entry 1 GRISE CHERYL W · CIK 0001192342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,019 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:27 UTC |
HASSELL GERALD LDirector
|
GrantCommon Stock | 520 | $72.15 | $37,518.00 |
DisclosureSEC source: 0001099219-23-000025 · wf-form4_167295400366113.xml · nonDerivative · entry 1 HASSELL GERALD L · CIK 0001209482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,966 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| December 23, 2022 Filed Apr 19, 2023 21:04 UTC |
HUBBARD ROBERT GLENNDirector
|
SaleCommon Stock | 6 | $72.24 | $433.44 |
DisclosureSEC source: 0001099219-23-000143 · wf-form4_168193828509148.xml · nonDerivative · entry 2 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,213 F1 · kind: These transactions were executed by an unaffiliated broker for an account of the reporting person managed by such broker, despite a trading restriction in the account prohibiting transactions in securities of the issuer. The broker did not discuss these transactions with the reporting person at the time the trades were made and the reporting person only recently became aware that such unauthorized transactions had occurred. Read SEC document |
| December 20, 2022 Filed Dec 22, 2022 21:15 UTC |
PODLOGAR SUSAN MEVP & Chief HR Officer
|
SaleCommon Stock | 3,000 | $71.91 | $215,730.00 |
DisclosureSEC source: 0001099219-22-000205 · wf-form4_167174371072649.xml · nonDerivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,193 Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:25 UTC |
MCKENZIE DIANADirector
|
GrantCommon Stock | 94 | $72.84 | $6,846.96 |
DisclosureSEC source: 0001099219-22-000203 · wf-form4_167122589949781.xml · nonDerivative · entry 1 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,830 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:25 UTC |
Kennard William EDirector
|
GrantCommon Stock | 230 | $72.84 | $16,753.20 |
DisclosureSEC source: 0001099219-22-000202 · wf-form4_167122587686728.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,783 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:24 UTC |
KELLY EDWARD J IIIDirector
|
GrantCommon Stock | 193 | $72.84 | $14,058.12 |
DisclosureSEC source: 0001099219-22-000201 · wf-form4_167122585590317.xml · nonDerivative · entry 1 KELLY EDWARD J III · CIK 0001160225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,288 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:24 UTC |
GRISE CHERYL WDirector
|
GrantCommon Stock | 489 | $72.84 | $35,618.76 |
DisclosureSEC source: 0001099219-22-000200 · wf-form4_167122583498926.xml · nonDerivative · entry 1 GRISE CHERYL W · CIK 0001192342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,499 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:23 UTC |
Kinney Catherine RDirector
|
GrantCommon Stock | 240 | $72.84 | $17,481.60 |
DisclosureSEC source: 0001099219-22-000199 · wf-form4_167122581568996.xml · nonDerivative · entry 1 Kinney Catherine R · CIK 0001205054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,994 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:23 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 507 | $72.84 | $36,929.88 |
DisclosureSEC source: 0001099219-22-000198 · wf-form4_167122579857795.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,171 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:23 UTC |
Herzog David LDirector
|
GrantCommon Stock | 39 | $72.84 | $2,840.76 |
DisclosureSEC source: 0001099219-22-000197 · wf-form4_167122577852510.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,749 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:22 UTC |
HASSELL GERALD LDirector
|
GrantCommon Stock | 112 | $72.84 | $8,158.08 |
DisclosureSEC source: 0001099219-22-000196 · wf-form4_167122575457392.xml · nonDerivative · entry 1 HASSELL GERALD L · CIK 0001209482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,446 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| December 12, 2022 Filed Dec 14, 2022 21:20 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 40,704 | $0.00 Strike: $31.15 | $0.00 |
DisclosureSEC source: 0001099219-22-000187 · wf-form4_167105282073539.xml · derivative · entry 3 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,704 shares Expires 2023-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Includes 4,340 stock options previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the stock options in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the stock options. F4 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 26, 2014, 2015 and 2016. Read SEC document |
| December 12, 2022 Filed Dec 14, 2022 21:20 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
SaleCommon Stock | 29,401 | $71.88 | $2,113,235.10 |
DisclosureSEC source: 0001099219-22-000187 · wf-form4_167105282073539.xml · nonDerivative · entry 2 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,310 F1 · shares: The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on December 12, 2022 and related tax obligations and fees. F2 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $71.59 and $72.27, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 12, 2022 Filed Dec 14, 2022 21:20 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
Exercise / conversionCommon Stock | 40,704 | $31.15 | $1,267,929.60 |
DisclosureSEC source: 0001099219-22-000187 · wf-form4_167105282073539.xml · nonDerivative · entry 1 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,711 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2022 Filed Dec 14, 2022 21:16 UTC |
Khalaf MichelDirector · President & CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 39,322 | $0.00 Strike: $34.33 | $0.00 |
DisclosureSEC source: 0001099219-22-000186 · wf-form4_167105257565012.xml · derivative · entry 5 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 39,322 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Includes 4,193 stock options previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the stock options in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the stock options. F6 · derivative.exercise_date: The options become exercisable in three substantially equal installments on February 23, 2016, 2017 and 2018. Read SEC document |
| December 12, 2022 Filed Dec 14, 2022 21:16 UTC |
Khalaf MichelDirector · President & CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 35,616 | $0.00 Strike: $31.15 | $0.00 |
DisclosureSEC source: 0001099219-22-000186 · wf-form4_167105257565012.xml · derivative · entry 4 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,616 shares Expires 2023-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Includes 3,798 stock options previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the stock options in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the stock options. F4 · derivative.exercise_date: The options become exercisable in three substantially equal installments on February 26, 2014, 2015 and 2016. Read SEC document |
| December 12, 2022 Filed Dec 14, 2022 21:16 UTC |
Khalaf MichelDirector · President & CEO
|
SaleCommon Stock | 57,201 | $72.49 | $4,146,637.77 |
DisclosureSEC source: 0001099219-22-000186 · wf-form4_167105257565012.xml · nonDerivative · entry 3 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,618 F1 · shares: The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on December 12, 2022 and related tax obligations and fees. F2 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $72.38 to $72.865, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 12, 2022 Filed Dec 14, 2022 21:16 UTC |
Khalaf MichelDirector · President & CEO
|
Exercise / conversionCommon Stock | 39,322 | $34.33 | $1,349,924.26 |
DisclosureSEC source: 0001099219-22-000186 · wf-form4_167105257565012.xml · nonDerivative · entry 2 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,819 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2022 Filed Dec 14, 2022 21:16 UTC |
Khalaf MichelDirector · President & CEO
|
Exercise / conversionCommon Stock | 35,616 | $31.15 | $1,109,438.40 |
DisclosureSEC source: 0001099219-22-000186 · wf-form4_167105257565012.xml · nonDerivative · entry 1 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 21:19 UTC |
PAPPAS BILLEVP, Global Tech. & Ops.
|
SaleCommon Stock | 5,000 | $75.55 | $377,725.00 |
DisclosureSEC source: 0001099219-22-000181 · wf-form4_167062077671937.xml · nonDerivative · entry 1 PAPPAS BILL · CIK 0001787586 · EVP, Global Tech. & Ops. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,147 Read SEC document |
| November 18, 2022 Filed Nov 22, 2022 21:17 UTC |
PAPPAS BILLEVP, Global Tech. & Ops.
|
Tax withholdingCommon Stock | 9,349 | $75.50 | $705,849.50 |
DisclosureSEC source: 0001099219-22-000179 · wf-form4_166915185805954.xml · nonDerivative · entry 1 PAPPAS BILL · CIK 0001787586 · EVP, Global Tech. & Ops. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,147 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:30 UTC |
KELLY EDWARD J IIIDirector
|
GrantCommon Stock | 599 | $62.62 | $37,509.38 |
DisclosureSEC source: 0001099219-22-000170 · wf-form4_166500181271382.xml · nonDerivative · entry 1 KELLY EDWARD J III · CIK 0001160225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,096 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:30 UTC |
Herzog David LDirector
|
GrantCommon Stock | 599 | $62.62 | $37,509.38 |
DisclosureSEC source: 0001099219-22-000169 · wf-form4_166500178969194.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,710 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:29 UTC |
GUTIERREZ CARLOS MDirector
|
GrantCommon Stock | 599 | $62.62 | $37,509.38 |
DisclosureSEC source: 0001099219-22-000168 · wf-form4_166500176724775.xml · nonDerivative · entry 1 GUTIERREZ CARLOS M · CIK 0001185943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,989 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:29 UTC |
GRISE CHERYL WDirector
|
GrantCommon Stock | 599 | $62.62 | $37,509.38 |
DisclosureSEC source: 0001099219-22-000167 · wf-form4_166500174312445.xml · nonDerivative · entry 1 GRISE CHERYL W · CIK 0001192342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,010 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:28 UTC |
MCKENZIE DIANADirector
|
GrantCommon Stock | 599 | $62.62 | $37,509.38 |
DisclosureSEC source: 0001099219-22-000166 · wf-form4_166500172332928.xml · nonDerivative · entry 1 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,735 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:28 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 1,098 | $62.62 | $68,756.76 |
DisclosureSEC source: 0001099219-22-000165 · wf-form4_166500169576590.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,664 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees and 50% of Board Chair retainer fees in MetLife, Inc. common stock. The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:28 UTC |
Kennard William EDirector
|
GrantCommon Stock | 599 | $62.62 | $37,509.38 |
DisclosureSEC source: 0001099219-22-000164 · wf-form4_166500167314788.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,552 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:27 UTC |
Kinney Catherine RDirector
|
GrantCommon Stock | 599 | $62.62 | $37,509.38 |
DisclosureSEC source: 0001099219-22-000163 · wf-form4_166500165064586.xml · nonDerivative · entry 1 Kinney Catherine R · CIK 0001205054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,754 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:27 UTC |
Harris Carla ADirector
|
GrantCommon Stock | 599 | $62.62 | $37,509.38 |
DisclosureSEC source: 0001099219-22-000162 · wf-form4_166500163202516.xml · nonDerivative · entry 1 Harris Carla A · CIK 0001707351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,532 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:27 UTC |
WEINBERGER MARK ADirector
|
GrantCommon Stock | 599 | $62.62 | $37,509.38 |
DisclosureSEC source: 0001099219-22-000161 · wf-form4_166500161366378.xml · nonDerivative · entry 1 WEINBERGER MARK A · CIK 0001785997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,045 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:26 UTC |
HASSELL GERALD LDirector
|
GrantCommon Stock | 599 | $62.62 | $37,509.38 |
DisclosureSEC source: 0001099219-22-000160 · wf-form4_166500158718445.xml · nonDerivative · entry 1 HASSELL GERALD L · CIK 0001209482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,334 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:26 UTC |
MORRISON DENISE MDirector
|
GrantCommon Stock | 599 | $62.62 | $37,509.38 |
DisclosureSEC source: 0001099219-22-000159 · wf-form4_166500157025181.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,955 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 20:26 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 544 | $66.41 | $36,127.04 |
DisclosureSEC source: 0001099219-22-000146 · wf-form4_166335999038060.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,566 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 20:26 UTC |
GRISE CHERYL WDirector
|
GrantCommon Stock | 528 | $66.41 | $35,064.48 |
DisclosureSEC source: 0001099219-22-000145 · wf-form4_166335997355229.xml · nonDerivative · entry 1 GRISE CHERYL W · CIK 0001192342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,411 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 20:25 UTC |
Kinney Catherine RDirector
|
GrantCommon Stock | 261 | $66.41 | $17,333.01 |
DisclosureSEC source: 0001099219-22-000143 · wf-form4_166335993789703.xml · nonDerivative · entry 1 Kinney Catherine R · CIK 0001205054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,155 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 20:26 UTC |
MCKENZIE DIANADirector
|
GrantCommon Stock | 98 | $66.41 | $6,508.18 |
DisclosureSEC source: 0001099219-22-000144 · wf-form4_166335995531873.xml · nonDerivative · entry 1 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,136 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 20:25 UTC |
Kennard William EDirector
|
GrantCommon Stock | 246 | $66.41 | $16,336.86 |
DisclosureSEC source: 0001099219-22-000141 · wf-form4_166335990027128.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,953 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 20:25 UTC |
HASSELL GERALD LDirector
|
GrantCommon Stock | 117 | $66.41 | $7,769.97 |
DisclosureSEC source: 0001099219-22-000142 · wf-form4_166335991773146.xml · nonDerivative · entry 1 HASSELL GERALD L · CIK 0001209482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,735 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 20:24 UTC |
Herzog David LDirector
|
GrantCommon Stock | 42 | $66.41 | $2,789.22 |
DisclosureSEC source: 0001099219-22-000139 · wf-form4_166335985245241.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,111 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 20:24 UTC |
KELLY EDWARD J IIIDirector
|
GrantCommon Stock | 205 | $66.41 | $13,614.05 |
DisclosureSEC source: 0001099219-22-000140 · wf-form4_166335987075723.xml · nonDerivative · entry 1 KELLY EDWARD J III · CIK 0001160225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,497 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| August 19, 2022 Filed Aug 23, 2022 21:20 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
Exercise / conversionEmployee Stock Options (right to buy) · Derivative | 5,513 | $0.00 Strike: $31.15 | $0.00 |
DisclosureSEC source: 0001770295-22-000002 · wf-form4_166128964225351.xml · derivative · entry 3 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,513 shares Expires 2023-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 26, 2014, 2015 and 2016. Read SEC document |
| August 19, 2022 Filed Aug 23, 2022 21:20 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
SaleCommon Stock | 4,060 | $67.60 | $274,456.00 |
DisclosureSEC source: 0001770295-22-000002 · wf-form4_166128964225351.xml · nonDerivative · entry 2 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,299 F1 · shares: The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on August 19, 2022 and related tax obligations and fees. Read SEC document |
| August 19, 2022 Filed Aug 23, 2022 21:20 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
Exercise / conversionCommon Stock | 5,513 | $31.15 | $171,729.95 |
DisclosureSEC source: 0001770295-22-000002 · wf-form4_166128964225351.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,359 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.